Page last updated: 2024-11-03

probenecid and Sarcoidosis

probenecid has been researched along with Sarcoidosis in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CHETRICK, A1

Other Studies

1 other study available for probenecid and Sarcoidosis

ArticleYear
COEXISTENT SARCOIDOSIS, ERYTHEMA NODOSUM, AND GOUT.
    JAMA, 1963, Dec-07, Volume: 186

    Topics: Cortisone; Deoxyribonuclease I; Erythema Nodosum; Gout; Humans; Isoniazid; Pathology; Prednisone; Pr

1963